Interparfums SA

LSE:0IUJ Stock Report

Market Cap: €3.0b

Interparfums Valuation

Is 0IUJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0IUJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0IUJ (€39.3) is trading below our estimate of fair value (€45.11)

Significantly Below Fair Value: 0IUJ is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0IUJ?

Key metric: As 0IUJ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0IUJ. This is calculated by dividing 0IUJ's market cap by their current earnings.
What is 0IUJ's PE Ratio?
PE Ratio26.9x
Earnings€110.80m
Market Cap€2.98b

Price to Earnings Ratio vs Peers

How does 0IUJ's PE Ratio compare to its peers?

The above table shows the PE ratio for 0IUJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.4x
W7L Warpaint London
24.7x11.8%UK£423.7m
APN Applied Nutrition
25.5xn/aUK£347.5m
HLN Haleon
28.5x10.6%UK£34.4b
VLG Venture Life Group
66.8x67.1%UK£49.6m
0IUJ Interparfums
26.9x10.3%€3.0b

Price-To-Earnings vs Peers: 0IUJ is good value based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (36.4x).

Price to Earnings Ratio vs Industry

How does 0IUJ's PE Ratio compare vs other companies in the European Personal Products Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0IUJ 26.9xIndustry Avg. 22.5xNo. of Companies5PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0IUJ is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the European Personal Products industry average (22.5x).

Price to Earnings Ratio vs Fair Ratio

What is 0IUJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0IUJ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.9x
Fair PE Ratio18x

Price-To-Earnings vs Fair Ratio: 0IUJ is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the estimated Fair Price-To-Earnings Ratio (18x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0IUJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€39.30
€48.90
+24.4%
13.0%€58.00€36.00n/a10
Nov ’25€40.95
€50.32
+22.9%
13.9%€61.20€36.00n/a10
Oct ’25€44.03
€51.73
+17.5%
13.5%€61.20€36.00n/a10
Sep ’25€45.30
€52.13
+15.1%
12.8%€61.20€36.00n/a10
Aug ’25€47.05
€52.13
+10.8%
12.8%€61.20€36.00n/a10
Jul ’25€39.05
€53.94
+38.1%
7.2%€61.82€49.09n/a9
Jun ’25€44.23
€54.44
+23.1%
7.8%€61.82€49.09n/a9
May ’25€43.23
€54.44
+25.9%
7.8%€61.82€49.09n/a9
Apr ’25€47.30
€53.01
+12.1%
9.5%€61.82€46.36n/a8
Mar ’25€46.91
€51.99
+10.8%
11.4%€61.82€45.45n/a8
Feb ’25€44.54
€51.25
+15.1%
12.1%€61.82€45.45n/a8
Jan ’25€45.94
€52.50
+14.3%
15.0%€68.18€45.45n/a8
Dec ’24€45.41
€52.50
+15.6%
15.0%€68.18€45.45n/a8
Nov ’24€40.88
€61.59
+50.7%
20.4%€81.82€45.45€40.957
Oct ’24€47.90
€64.19
+34.0%
16.7%€81.82€46.36€44.037
Sep ’24€55.00
€65.75
+19.5%
13.7%€81.82€52.73€45.307
Aug ’24€58.75
€64.36
+9.5%
12.2%€75.45€50.41€47.057
Jul ’24€59.31
€62.09
+4.7%
10.8%€71.90€50.41€39.057
Jun ’24€56.11
€61.16
+9.0%
9.6%€71.90€50.41€44.238
May ’24€59.39
€58.88
-0.9%
7.9%€66.12€50.41€43.238
Apr ’24€57.02
€54.19
-5.0%
3.6%€57.02€50.41€47.307
Mar ’24€54.96
€52.27
-4.9%
7.2%€56.20€44.63€46.916
Feb ’24€49.84
€50.48
+1.3%
6.7%€54.55€44.63€44.546
Jan ’24€46.16
€46.69
+1.2%
5.2%€50.41€42.98€45.946
Dec ’23€44.88
€46.14
+2.8%
3.9%€47.93€42.98€45.416
Nov ’23€40.28
€43.91
+9.0%
6.8%€46.28€38.02€40.886

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Ontex Group

€620.0m

Develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally.

0QVQ

€7.59

7D

2.4%

1Y

7.7%

McBride

UK£182.8m

Manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Italy, Spain, rest of Europe, Asia-Pacific, and internationally.It operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.

MCBL

UK£1.05

7D

3.5%

1Y

71.3%

Suominen Oyj

€174.5m

Manufactures and sells nonwovens as roll goods for wipes and other applications in Finland, the Americas, the rest of Europe, and internationally.

0M1M

€2.65

7D

0%

1Y

-47.8%